David Evans is the Head of Discovery Research and co-founder of Sirnaomics, where he leads the development of siRNA therapeutics for oncology, fibrosis, and infectious diseases. An alumnus of Imperial College London, he is a seasoned R&D leader with extensive experience in driving multiple drug candidates from discovery to clinical-stage trials.
He is described as a creative leader who is rich in ideas for new technological solutions to problems in drug screening. People who have worked with him note that he fosters an innovative and enjoyable work environment.
Interesting fact: David is a serial entrepreneur, having co-founded several therapeutic, diagnostic, and instrumentation companies throughout his career.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.